Form D · Biotechnology
IMAGINOSTICS, INC.
Orlando, FL · CIK 0002122464
Offering snapshot reported May 29, 2026 · SEC filing
- Reported sold
- $40K Indefinite offering
- Investors reported
- 1 Form D · investor count
- Minimum accepted
- $0 Reported outside-investor minimum
- First sale
- May 14, 2026 As reported in this filing
What changed?
Latest filing versus its linked predecessor, where available.
No comparable changes in the displayed metrics.
Filing history
Scroll to see all columns →
| Filed | Filing type | Reported sold | Change vs linked filing | Investors | Source |
|---|---|---|---|---|---|
| May 29, 2026 | Initial | $40,000 | No comparison | 1 | SEC filing |
| Apr 8, 2026 | Amendment | $50,000 | -$450,000vs Apr 6, 2026 | 1 | SEC filing |
| Apr 6, 2026 | Initial | $725,274 | No comparison | 1 | SEC filing |
| Apr 6, 2026 | Initial | $5,353,594 | No comparison | 75 | SEC filing |
| Apr 6, 2026 | Initial | $500,000 | No comparison | 1 | SEC filing |
| Apr 3, 2026 | Initial | $100,000 | No comparison | 1 | SEC filing |
| Apr 3, 2026 | Initial | $516,900 | No comparison | 18 | SEC filing |
| Apr 3, 2026 | Initial | $400,000 | No comparison | 5 | SEC filing |
Offering details
- Securities
- Equity, Option to acquire, Security to be acquired, Other
- Exemptions
- 06b
- Duration over one year
- Yes
- Business combination
- No
- Sales commissions
- $0
- Finders' fees
- $0
- Form D file number
- 021-585579
These securities are Simple Agreements for Future Equity (SAFEs), which are convertible into equity securities of the issuer,typically preferred stock,upon the occurrence of specified triggering events including future financingroundS.
Source: Form D, filed May 29, 2026. Minimum accepted may differ from a standard advertised minimum.
Fund connections
No confirmed ADV fund connection is available for this issuer.
People & organizations
Current and past Form D appearances. These existing records do not establish a person's current role or uniquely identify them across issuers.
| Name | Reported role |
|---|---|
| Codi Gharagouzloo | Director, Executive, Promoter |
| Valerie Aimee Gharagouzloo | Director, Executive, Promoter |
| Scott Hoge | Executive |
| William Scott Hoge | Executive |
| Scott Sc Hoge | Executive |
Issuer details
Industry: Biotechnology (See others in industry)
Address:
C/O Guidewill Innovation Center 6555 Sanger Rd. Suite 100
Orlando, FL, 32827
Orlando, FL, 32827